Lexapro SSRI Switch Plan On Target Despite Slower Than Expected Decline In Celexa Sales
This article was originally published in The Pink Sheet Daily
Executive Summary
Forest attributes the majority of Celexa’s $15.4 mil. sequential quarterly sales growth to a 4% price increase taken in March. Forest’s estimates put the Celexa revenue run rate in early 2005 at $680 mil., above earlier predictions.